Luke Pittman
About Luke Pittman
Luke Pittman is the Business Unit Director for Rhythm Management at Boston Scientific, overseeing operations in Australia and New Zealand since 2020.
Current Title and Role
Luke Pittman currently serves as the Business Unit Director for Rhythm Management at Boston Scientific. He has been in this role since 2020, overseeing operations in Australia and New Zealand. His responsibilities likely include managing business strategies, ensuring product performance, and leading regional teams to achieve company objectives.
Previous Positions at Boston Scientific
Luke Pittman has held multiple positions at Boston Scientific over the years. From 2018 to 2020, he was a Corporate Accounts Manager in QLD and NSW. Before that, he served as a Regional Sales Manager for CRM & EP from 2012 to 2017 in QLD. He also worked as a Marketing Manager for CRM & EP from 2011 to 2012, and as an Area Manager for CRM from 2009 to 2011 in NSW. From 2005 to 2008, he was a Territory Manager for CRM, and earlier, from 2003 to 2005, a Clinical Specialist for CRM, both roles based in NSW.
Educational Background
Luke Pittman attended Charles Sturt University, where he achieved a Diploma of Education, Secondary (PD/H/PE) in 1998. He also completed a Bachelor's Degree in Human Movement from the same institution, studying from 1995 to 1997. His educational background provides a strong foundation in physical education and human movement sciences.
Experience in Australia and New Zealand
Luke Pittman has a long history of working in Australia and New Zealand, particularly in roles related to cardiac rhythm management (CRM). His expertise has been developed over numerous positions within Boston Scientific, including Business Unit Director, Corporate Accounts Manager, Regional Sales Manager, Marketing Manager, Area Manager, Territory Manager, and Clinical Specialist. His geographical focus has primarily been in the states of New South Wales and Queensland, as well as broad oversight of operations in both Australia and New Zealand.